Partnership for Research on Ebola VACcinations

Condition:   Ebola Virus Disease Interventions:   Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: rVSVΔG-ZEBOV-GP;   Biological: Placebo;   Biological: rVSV boost Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   The Liberia-US Clinical Trials Partnership Program, Partnership for Research on Ebola Virus in Liberia Project (PREVAIL);   Institut National de la Santé Et de la Recherche Médicale, France;   London School of Hygiene& Tropical Medicine (LSHTM) Not yet recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials